Qrons: Qrons Inc.: Qrons files U.S. National Phase of its Patent Application in Furtherance of its QS200 Product Candidate for Therapeutic Polypseudorotaxane Hydrogels

NEW YORK, NY / ACCESSWIRE / March 22, 2023 / Qrons Inc. (OTCQB:QRON), an innovative biotechnology company dedicated to developing biotech products, treatments and technologies that create a platfor...